Literature DB >> 9094663

Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir.

J J Sasadeusz1, F Tufaro, S Safrin, K Schubert, M M Hubinette, P K Cheung, S L Sacks.   

Abstract

In the majority of cases, the mechanism underlying the resistance to acyclovir (ACV) of herpes simplex viruses (HSVs) is thymidine kinase (TK) deficiency. Plaque isolates from eight ACV-resistant (ACVr) clinical isolates from AIDS patients, of which five reactivated, were sequenced to determine the genetic lesion within the tk gene conferring resistance and whether this may have correlated with reactivation potential. Mutations were clustered within two homopolymer nucleotide stretches. Three plaque isolates (1737-14, 90-150-3, and 89-650-5) had insertion mutations within a stretch of 7 guanosines, while two isolates (89-063-1 and 89-353-1) had frameshift mutations within a stretch of 6 cytosines (a deletion and an insertion, respectively). Mutations resulted in premature termination codons, and the predicted 28- and 32-kDa truncated TK products were detected by Western blot analysis of virus-infected cell extracts. The repair of one homopolymer frameshift mutation (in isolate 1737-14) restored TK activity, demonstrating that this mutation is the basis of TK deficiency. Of the five reactivated isolates, four were TK deficient and contained frameshift mutations while the fifth retained TK activity because of its altered-TK or Pol- phenotype. These data demonstrate that the majority of ACVr clinical isolates contain frameshift mutations within two long homopolymer nucleotide stretches which function as hot spots within the HSV tk gene and produce nonfunctional, truncated TK proteins.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094663      PMCID: PMC191538     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Genetic studies of the lac repressor. VII. On the molecular nature of spontaneous hotspots in the lacI gene of Escherichia coli.

Authors:  P J Farabaugh; U Schmeissner; M Hofer; J H Miller
Journal:  J Mol Biol       Date:  1978-12-25       Impact factor: 5.469

2.  Molecular basis of a mutational hot spot in the lysozyme gene of bacteriophage T4.

Authors:  Y Okada; G Streisinger; J E Owen; J Newton; A Tsugita; M Inouye
Journal:  Nature       Date:  1972-04-14       Impact factor: 49.962

3.  Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy.

Authors:  W H Burns; R Saral; G W Santos; O L Laskin; P S Lietman; C McLaren; D W Barry
Journal:  Lancet       Date:  1982-02-20       Impact factor: 79.321

4.  Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir.

Authors:  C S Crumpacker; L E Schnipper; S I Marlowe; P N Kowalsky; B J Hershey; M J Levin
Journal:  N Engl J Med       Date:  1982-02-11       Impact factor: 91.245

5.  rII cistrons of bacteriophage T4. DNA sequence around the intercistronic divide and positions of genetic landmarks.

Authors:  D Pribnow; D C Sigurdson; L Gold; B S Singer; C Napoli; J Brosius; T J Dull; H F Noller
Journal:  J Mol Biol       Date:  1981-07-05       Impact factor: 5.469

6.  Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir.

Authors:  J C Wade; C McLaren; J D Meyers
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

7.  Herpes simplex virus resistant to acyclovir. A study in a tertiary care center.

Authors:  J A Englund; M E Zimmerman; E M Swierkosz; J L Goodman; D R Scholl; H H Balfour
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

8.  Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.

Authors:  J C Wade; B Newton; N Flournoy; J D Meyers
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

9.  Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions.

Authors:  F P Siegal; C Lopez; G S Hammer; A E Brown; S J Kornfeld; J Gold; J Hassett; S Z Hirschman; C Cunningham-Rundles; B R Adelsberg
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

10.  Nucleotide sequence of the herpes simplex virus type 2 (HSV-2) thymidine kinase gene and predicted amino acid sequence of thymidine kinase polypeptide and its comparison with the HSV-1 thymidine kinase gene.

Authors:  S Kit; M Kit; H Qavi; D Trkula; H Otsuka
Journal:  Biochim Biophys Acta       Date:  1983-11-17
View more
  44 in total

Review 1.  The role of DNA amplification technology in the diagnosis of infectious diseases.

Authors:  M Louie; L Louie; A E Simor
Journal:  CMAJ       Date:  2000-08-08       Impact factor: 8.262

2.  Selection and characterization of varicella-zoster virus variants resistant to (R)-9-[4-hydroxy-2-(hydroxymethy)butyl]guanine.

Authors:  T I Ng; Y Shi; H J Huffaker; W Kati; Y Liu; C M Chen; Z Lin; C Maring; W E Kohlbrenner; A Molla
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.

Authors:  Dongli Pan; Donald M Coen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

Review 4.  Slipping and sliding: frameshift mutations in herpes simplex virus thymidine kinase and drug-resistance.

Authors:  Anthony Griffiths
Journal:  Drug Resist Updat       Date:  2011-09-22       Impact factor: 18.500

Review 5.  Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

6.  Characterization of herpes simplex virus type 1 thymidine kinase mutants selected under a single round of high-dose brivudin.

Authors:  Graciela Andrei; Jan Balzarini; Pierre Fiten; Erik De Clercq; Ghislain Opdenakker; Robert Snoeck
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  An unusual internal ribosome entry site in the herpes simplex virus thymidine kinase gene.

Authors:  Anthony Griffiths; Donald M Coen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-22       Impact factor: 11.205

8.  Low-level expression and reversion both contribute to reactivation of herpes simplex virus drug-resistant mutants with mutations on homopolymeric sequences in thymidine kinase.

Authors:  Anthony Griffiths; Malen A Link; Caroline L Furness; Donald M Coen
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

9.  Mutation hot spots in the canine herpesvirus thymidine kinase gene.

Authors:  Shinya Yamada; Yasunobu Matsumoto; Yasuhiro Takashima; Haruki Otsuka
Journal:  Virus Genes       Date:  2005-08       Impact factor: 2.332

10.  Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.

Authors:  Michael I Besecker; Caroline L Furness; Donald M Coen; Anthony Griffiths
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.